The gene therapy sector is booming, but can the industry address all the teething problems?

The cell and gene therapy industry has amazing statistics. But to reach the next level, the industry must address its talent gap.

How an understanding of the regulatory framework is essential for the future generations of cell and gene therapy professionals.

Contract laboratories need to be treated as equal partners rather than service providers.

Cell and gene therapies require the very highest levels of quality, so an effective fill-finish solution is essential to manufacturing operations.

The Pistoia Alliance have announced their plans to develop a toolkit to help companies navigate large datasets.

Dutch authorities hand over the keys to the EMA's new building in Amsterdam.

The UK’s “sovereignty” debate does not end with an agreed UK-EU relationship. It extends to all trading partners...

Hovione’s New Jersey-based site has provided process development and small volume API manufacturing since 2002.

The reported benefits of continuous manufacturing for small molecules over batch manufacturing include accelerated product and process development.